- Home
- APGE vs DAN Comparison
APGE vs DAN Comparison
Compare APGE & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- DAN
- Stock Information
- Founded
- APGE 2022
- DAN 1904
- Country
- APGE United States
- DAN United States
- Employees
- APGE N/A
- DAN N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- DAN Auto Parts:O.E.M.
- Sector
- APGE Health Care
- DAN Consumer Discretionary
- Exchange
- APGE Nasdaq
- DAN Nasdaq
- Market Cap
- APGE 2.3B
- DAN 2.0B
- IPO Year
- APGE 2023
- DAN N/A
- Fundamental
- Price
- APGE $34.55
- DAN $15.71
- Analyst Decision
- APGE Strong Buy
- DAN Buy
- Analyst Count
- APGE 5
- DAN 8
- Target Price
- APGE $83.50
- DAN $17.71
- AVG Volume (30 Days)
- APGE 514.4K
- DAN 1.9M
- Earning Date
- APGE 03-04-2025
- DAN 02-20-2025
- Dividend Yield
- APGE N/A
- DAN 2.55%
- EPS Growth
- APGE N/A
- DAN N/A
- EPS
- APGE N/A
- DAN N/A
- Revenue
- APGE N/A
- DAN $10,284,000,000.00
- Revenue This Year
- APGE N/A
- DAN N/A
- Revenue Next Year
- APGE N/A
- DAN N/A
- P/E Ratio
- APGE N/A
- DAN N/A
- Revenue Growth
- APGE N/A
- DAN N/A
- 52 Week Low
- APGE $32.46
- DAN $7.58
- 52 Week High
- APGE $72.29
- DAN $16.90
- Technical
- Relative Strength Index (RSI)
- APGE 35.39
- DAN 55.95
- Support Level
- APGE $32.46
- DAN $15.79
- Resistance Level
- APGE $37.42
- DAN $16.90
- Average True Range (ATR)
- APGE 2.17
- DAN 0.55
- MACD
- APGE -0.30
- DAN -0.16
- Stochastic Oscillator
- APGE 20.84
- DAN 26.99
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About DAN Dana Incorporated
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.